Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-23-000179
Filing Date
2023-01-03
Accepted
2023-01-03 06:08:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-3/A d420468ds3a.htm S-3/A 66414
2 EX-23.2 d420468dex232.htm EX-23.2 1881
  Complete submission text file 0001193125-23-000179.txt   69500
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-269059 | Film No.: 23500069
SIC: 2835 In Vitro & In Vivo Diagnostic Substances